Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT04410965

Completed

Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks (TERI-PK)

Multiple Sclerosis
NCT06064539

Completed

Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

Multiple Sclerosis
NCT03368677

Active, not recruiting

Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression (TERIPET)

Multiple Sclerosis
NCT05853835

Completed

First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641

Multiple Sclerosis | Autoimmune Diseases
NCT05442112

Completed

Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes

Multiple Sclerosis
NCT03021317

Terminated

Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses (ACTHAR)

Multiple Sclerosis
NCT05209815

Completed

Safety of Exposure to Natalizumab During Pregnancy (BABYZUMAB-2)

Multiple Sclerosis
NCT03198351

Completed

An Observational Study on Teriflunomide-exposed Pregnancies

Multiple Sclerosis
NCT01967160

Completed

Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid

Osteonecrosis of the Jaw | Infection Leading to Hospitalization
NCT03122652

Completed

Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome (TERIS)

Multiple Sclerosis
NCT05141669

Completed

Impact of Fingolimod Adherence on Outcomes

Multiple Sclerosis
NCT04823936

Completed

Core Stability in Ataxic Cerebral Palsied Children

Core Stability | Ataxic Cerebral Palsied Children | Balance and Coordination | Severity of the Ataxia
NCT04635033

Completed

Intermittent Hypoxia Intervention in MS Patients (MSHYPE)

Multiple Sclerosis
NCT03574428

Completed

Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

Multiple Sclerosis
NCT02987621

Completed

Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS?

Multiple Sclerosis
NCT02201849

Completed

A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults

Multiple Sclerosis
NCT04082260

Unknown

Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS: Markers for Risk Stratification and Treatment Response (ProgramMS)

Multiple Sclerosis
NCT02263339

Completed

Exercise & Brain Health in MS

Multiple Sclerosis
NCT03047460

Completed

Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting

Multiple Sclerosis
NCT02146534

Completed

Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients

Multiple Sclerosis
NCT02079025

Completed

Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer

Prostatic Neoplasms | Prostate Cancer | Cancer of the Prostate
NCT03703180

Unknown

Vision Assessment With the Quick Contrast Sensitivity Function (qCSF) Method in Healthy Controls and MS (VICTOR2)

Multiple Sclerosis
NCT03647904

Unknown

The SEMS Project: Staying Employed With MS

Multiple Sclerosis
NCT03092544

Unknown

Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients

Multiple Sclerosis
NCT01802931

Completed

GSK239512 DDI Study

Multiple Sclerosis
NCT02969304

Completed

Study of Utilization Patterns of Dimethyl Fumarate in Germany

Multiple Sclerosis
NCT03206034

Completed

Stylistic Memory Enhancement (SME)

Multiple Sclerosis
NCT01387217

Completed

GSK2018682 FTIH in Healthy Volunteers (P1A114070)

Multiple Sclerosis
NCT01112722

Completed

Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis

Osteoarthritis of the Knee
NCT02736279

Unknown

Impact of Tecfidera on Gut Microbiota

Multiple Sclerosis
NCT02775110

Completed

Natalizumab Temporary Discontinuation Study (NaTDS)

Multiple Sclerosis
NCT02419638

Withdrawn

Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS

Multiple Sclerosis
NCT02518776

Unknown

Influence of Emotional Disorders and Executive on the Components Retrograde and Anterograde Episodic Memory in MS (ITEMS)

Multiple Sclerosis
NCT00338741

Completed

Rebif® Pregnancy Registry

Multiple Sclerosis
NCT01752660

Completed

Exercise in Severely Disabled Patients With MS

Multiple Sclerosis
NCT00691977

Withdrawn

Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate

Prostate Cancer
NCT01500408

Completed

Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers

Multiple Sclerosis
NCT00752778

Terminated

Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri

Multiple Sclerosis
NCT01335633

Completed

Psychometric Validation of Cognitive Endpoints

Multiple Sclerosis
NCT01521806

Unknown

Effects of Dietary Fiber on Insulin Sensitivity

Focus of the Study is Insulin Sensitivity
NCT01137630

Completed

Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp

Seborrhoeic Dermatitis of the Scalp
NCT01443065

Completed

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma (MEGA)

Malignant Neoplasm of Stomach | Malignant Neoplasm of Esophagus
NCT04610437

Completed

Intramedullary Resorbable Fixation System Versus K-wire for the Treatment of Lesser Toe Deformities

Surgery | Hammer Toe | Deformity of Toe | Phalanx; Dislocation Toe(S)
NCT03511196

Active, not recruiting

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Prostate Cancer | Advanced Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer
NCT06422702

Active, not recruiting

The Effect of a Psychosomatic Symptom Intervention Program on the Primary Treatment of Differentiated Thyroid Cancer

Pathologically Confirmed Differentiated Thyroid Carcinoma | All Patients Are in the Initial Treatment Phase | Normal Cognitive and Communicative Abilities, Capable of Reading and Understanding Questionnaires in Chinese | Ability to Use a Smartphone | Voluntary Participation in the Study and Signed Informed Consent
NCT06920524

Recruiting

Interest of a Musical Intervention on Stress Induced During Botulinum Toxin Injections in Spasticity (MUSIBOT) (MUSIBOT)

Stroke | Multiple Sclerosis | Spinal Cord Injury | Head Trauma Injury
NCT04315883

Terminated

Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

Hepatocellular Carcinoma | Hepatoblastoma | Liver Tumors | Rhabdoid Tumor of Liver | Undifferentiated (Embryonal) Sarcoma of the Liver | Pediatric Liver Cancer
NCT00004922

Completed

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Neuroendocrine Carcinoma | Carcinoma of Unknown Primary | Neuroendocrine Carcinoma of the Skin
NCT04609566

Completed

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Melanoma | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer
NCT02575404

Completed

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Melanoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations